Pineapple Express Cannabis (PNXP) Invested Capital (2018 - 2025)
Pineapple Express Cannabis' (PNXP) quarterly Invested Capital came in at -$5.1 million in Q4 2025, down 18005.19% year-on-year from N/an in Q4 2024, and little changed quarter-over-quarter from -$5.1 million in Q3 2025.
Pineapple Express Cannabis (PNXP) Invested Capital (2018 - 2025) Analysis & Trends
Pineapple Express Cannabis has disclosed Invested Capital across 8 years of filings, most recently posting -$5.1 million for Q4 2025.
- Invested Capital for Q4 2025 came in at -$5.1 million, down 18005.19% year-over-year; the trailing twelve-month figure through Oct 2025 was -$5.1 million (down 18005.19% YoY), and the FY2025 annual result was -$2079.0, up 86.95% from the prior year.
- Invested Capital came in at -$5.1 million for Q4 2025 at Pineapple Express Cannabis, roughly flat from -$5.1 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $1.1 million in Q4 2023 to a low of -$5.1 million in Q3 2025.
- The 5-year median for Invested Capital is $10621.0 (2022), against an average of -$663051.1.
- Across the five-year window, Invested Capital jumped 10208.38% in 2023 and slumped 18867.59% in 2025, its largest moves.
- Pineapple Express Cannabis' Invested Capital stood at -$53505.0 in 2021, then surged by 119.22% to $10286.0 in 2022, then surged by 10208.38% to $1.1 million in 2023, then plunged by 97.31% to $28502.0 in 2024, then slumped by 18005.19% to -$5.1 million in 2025.
- The last three Invested Capital figures came in at -$5.1 million (Q4 2025), -$5.1 million (Q3 2025), and -$4.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 10.84 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 479.60 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 10.24 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.78 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 446.17 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.79 Bn |
| 10 | Pineapple Express Cannabis | - | - | - | -5.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | -5.10 Mn |
| Jul 31, 2025 | -5.12 Mn |
| Apr 30, 2025 | -4.78 Mn |
| Jan 31, 2025 | -2,079.00 |
| Oct 31, 2024 | 28,502.00 |
| Jul 31, 2024 | 29,750.00 |
| Apr 30, 2024 | 25,458.00 |
| Jan 31, 2024 | -15,926.00 |
| Oct 31, 2023 | 1.06 Mn |
| Jul 31, 2023 | 919,158.00 |
| Apr 30, 2023 | 305,245.00 |
| Jan 31, 2023 | -544,350.00 |
| Oct 31, 2022 | 10,286.00 |
| Jul 31, 2022 | 10,956.00 |
| Apr 30, 2022 | 12,081.00 |
| Jan 31, 2022 | 13,610.00 |
| Oct 31, 2021 | -53,505.00 |
| Jul 31, 2021 | -52,478.00 |
| Apr 30, 2021 | -28,585.00 |
| Jan 31, 2021 | 20,222.00 |